Posición de la Academia Nacional de Medicina de México con relación con el decreto presidencial por el que se reforman y adicionan diversas disposiciones de la Ley General de Salud, en específico aquella donde faculta a la Secretaría de Salud para diseñar y ejecutar políticas públicas que regulen el uso medicinal y científico de los derivados farmacológicos de la Cannabis sativa indica americana o marihuana, entre los que se encuentra el tetrahidrocannabinol, sus isómeros y variantes estereoquím

As a consequence of the Presidential Decree that reforms and additions the General Statute of Health with regard to medicinal and scientific use of tetrahydrocannabinol, its isomers and stereochemical variants, the National Academy of Medicine of Mexico declares its position in favor of regulating i...

Full description

Saved in:
Bibliographic Details
Published inGaceta médica de México Vol. 154; no. 6; pp. 737 - 739
Main Authors Mansilla-Olivares, Armando, Plancarte-Sánchez, Ricardo, Meneses-González, Fernando, Valenzuela-Gómez-Gallardo, Fermín, López-Bárcena, Joaquín, Velasco-Monroy, Ana Luisa, Anda, Gilberto Felipe Vázquez-De, Santos-Preciado, José Ignacio
Format Journal Article
LanguageSpanish
Published Mexico 2018
Subjects
Cannabis therapeutic use
Cannabis
Tetrahidrocannavinol
Uso terapéutico de la Cannabis
Tetrahydrocannabinol
Online AccessGet full text

Cover

More Information
Summary:As a consequence of the Presidential Decree that reforms and additions the General Statute of Health with regard to medicinal and scientific use of tetrahydrocannabinol, its isomers and stereochemical variants, the National Academy of Medicine of Mexico declares its position in favor of regulating investigation and national production thereof.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0016-3813
DOI:10.24875/GMM.18004744